High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
about
CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistancePrognostic role of CIP2A expression in serous ovarian cancerExpression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.Identification of genes associated with tongue cancer in patients with a history of tobacco and/or alcohol use.Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers.Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin.Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.The association and prognostic relevance of cancerous inhibitor of protein phosphatase 2A and inflammation in tongue squamous cell carcinoma.CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus.High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosis.CIP2A expression and prognostic role in patients with esophageal adenocarcinoma.Increased expression of CIP2A in aggressive subtypes of B-cell lymphoma.CIP2A overexpression is associated with c-Myc expression in colorectal cancer.CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.
P2860
Q27853345-8FB5B204-61A9-42A5-8194-9D404E9486F2Q31137535-737D21B5-95D7-435D-84C8-35A6F1B0A365Q33712856-A476B159-CAD1-4178-B9DC-BEA1796BC266Q35238413-312C07E3-073E-4AD6-BA78-196EC10A99E1Q35263210-E272D117-0A82-4434-A0BE-3A10CC4CC1ACQ35653981-8234B007-087C-4525-A0A7-E0AB62A21F50Q35755402-6101CE23-C7E1-4C4D-995D-C49BD2DDB976Q36283436-DF13AA5B-7E74-4C42-BBC1-75D23115BAA0Q36777896-099341B7-4EF7-4E7F-B4D5-12980BCCC0B2Q36897929-44894A8B-A717-4A72-BF43-56054C2256AAQ37428639-A571F25B-64D2-47DC-B8CD-D2F9576FD0D1Q37700692-9760DD6B-4B69-441F-9C7A-80FEB819A6FBQ38157868-304C762A-6893-4671-9F06-8B2B7A0C19FDQ38228491-E5DCFCC7-D1D7-42FB-B866-C99232CD1225Q38335027-6C819A3E-A127-4C41-8C5C-2EA8D4E12DDDQ38830273-EF47A085-E653-4EF0-A34F-D8F7A4E36708Q38990407-230690E3-B6C5-4248-8CFD-0B9645DEB9F3Q39001461-71CBE4BF-2479-414A-94E2-580CCF92437AQ39039799-820EA17A-CDC9-4009-B9B2-6D79598DEC13Q39218849-FDCE34EF-08E3-452C-AC20-06FF3F66B6B9Q39358186-A519D860-D0FA-44E8-B0DB-414979A17697Q40104856-F67C0D62-19BE-4CEE-B6F8-E2137A034887Q41160985-0262A23A-86B3-4F96-AE91-698811C0E021Q42206331-0052041F-1CB0-48B1-B0C9-549CF75B9759Q47110572-C50E0454-97FF-4B62-A59D-357370679071Q47832427-160B08A3-D155-4AF0-95B5-F7E3198FC7A7Q50876945-23ED005B-299C-400D-8A74-36678E9ECB85Q50969099-A7F10567-98D8-48EE-9D4D-371C7140CFCEQ51158345-318E23F5-4D2C-4CAF-BC58-023BF2792376
P2860
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@ast
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@en
type
label
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@ast
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@en
prefLabel
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@ast
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@en
P2093
P2860
P356
P1476
High CIP2A immunoreactivity is ...... in early-stage tongue cancer.
@en
P2093
A Ristimäki
C Böckelman
H Keski-Säntti
J Hagström
L K Mäkinen
P2860
P2888
P304
P356
10.1038/BJC.2011.167
P407
P577
2011-05-24T00:00:00Z
P5875
P6179
1030638509